AMBEV S.A. current report, Q3 FY2021

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the month of July 2021, with the report signed on August 9, 2021. The document serves as a compliance report under Article 11 of CVM Instruction # 358/2002, detailing transactions of securities and derivatives by the company's Board of Directors, Management, and Fiscal Council.

Key Financial Metrics

The filing text does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly limited to reporting changes in equity holdings by related persons.

Material Changes in Securities Holdings

The following changes in securities positions were reported for July 2021:

  • Board of Directors:
    • Initial Balance: 32,373,942 Common Shares and 1,136,139 ADRs.
    • Transaction: Renunciation of 17,985 Common Shares on July 1st (Volume: R$ 0.00).
    • Final Balance: 32,355,957 Common Shares and 1,136,139 ADRs.
  • Management:
    • Initial Balance: 5,383,890 Common Shares and 553,648 ADRs.
    • Transaction: No transactions reported.
    • Final Balance: 5,383,890 Common Shares and 553,648 ADRs.
  • Fiscal Council:
    • Initial Balance: 0 Common Shares.
    • Transaction: No transactions reported.
    • Final Balance: 0 Common Shares.

Guidance, Outlook, and Risks

The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. The document is a regulatory disclosure of insider trading activity only.

Investor Verification Checklist

  • Verify the specific reason for the renunciation of 17,985 shares by the Board of Directors, as the price and volume were reported as zero.
  • Confirm that no other material transactions occurred outside the scope of this specific CVM Instruction report.
  • Review the company's quarterly or annual reports (Form 20-F) for actual financial performance metrics, as they are absent in this filing.